Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Market Cap

Capricor Therapeutics has a market cap or net worth of $344.76 million as of October 23, 2026. It is the 16,857th most valuable company in the world and the 3,007th biggest in the United States. Its market cap has increased by 21.05% in one year.

• Market Cap: 344.76M
• Enterprise Value: 197.87M
• 1-Year Change: 21.05%
• Global Rank: #16,857
• Country Rank: #3,007 United States
• Category: Small-Cap

Market Cap Chart

Chart

Since May 13, 2008, Capricor Therapeutics's market cap has increased from $130.10M to $344.76M, an increase of 165.00%. That is a compound annual growth rate of 5.42%.

Market Cap History

Date	Market Cap	% Change
Oct 23, 2026	344.76M	-73.87%
Dec 31, 2025	1.32B	110.26%
Dec 31, 2024	627.50M	316.67%
Dec 29, 2023	150.60M	54.62%
Dec 30, 2022	97.40M	37.57%
Dec 31, 2021	70.80M	1.00%
Dec 31, 2020	70.10M	1,198.15%
Dec 31, 2019	5.40M	-57.48%
Dec 31, 2018	12.70M	-68.72%
Dec 29, 2017	40.60M	-28.65%
Dec 30, 2016	56.90M	13.80%
Dec 31, 2015	50.00M	13.90%
Dec 31, 2014	43.90M	1,467.86%
Dec 31, 2013	2.80M	27.27%
Dec 31, 2012	2.20M	-89.91%
Dec 30, 2011	21.80M	1.40%
Dec 31, 2010	21.50M	-36.39%
Dec 31, 2009	33.80M	38.52%
Dec 31, 2008	24.40M	-81.25%
May 13, 2008	130.10M	-

View and export this data all the way back to 2008. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Oct 22, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Oct 23, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Editas Medicine	382.41M
Prelude Therapeutics	370.78M
Fennec Pharmaceuticals	361.89M
Kyverna Therapeutics	354.36M
Relmada Therapeutics	350.94M
Galectin Therapeutics	340.87M
Scribe Therapeutics	340.01M
Enanta Pharmaceuticals	338.44M